BioMarin enters share purchase agreement for acquisition
BioMarin Pharmaceutical Inc. entered into a share purchase agreement with Alesta Therapeutics B.V. and related shareholders. The transaction is expected to be completed in 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day